Allevia Ingredients
Allergies can sometimes hold you back, but relief is at hand with Fexofenadine, a selective peripheral H1 blocker. Fexofenadine is a second-generation non-drowsy antihistamine which does not cross the blood-brain barrier in most people.
At Allevia, we value transparency. For those with intolerances, our tablets are gluten & lactose free. For more detail about our ingredients, please see the list below:
The active substance is fexofenadine hydrochloride. Each tablet contains 120 mg of fexofenadine hydrochloride.
The other ingredients are:
- Tablet core: microcrystalline cellulose, pregelatinised maize starch, croscarmellose sodium, magnesium stearate.
- Film coating: hypromellose, povidone K30, titanium dioxide (E171), colloidal anhydrous silica, macrogol 400, red iron oxide (E172) and yellow iron oxide (E172).
Packaging
Allevia is on a green mission! By the end of 2024, we plan to use recycled or FSC certified materials for our cartons and leaflets, promoting sustainable forest management. We're also minimizing packaging where possible.
Our 2025 goal? All paper from sustainable sources.
Look out for the FSC/SFI logo on our packaging, a testament to our commitment.
Disposal
The Allevia carton is recyclable in usual household waste recycling. For blisters packs, these are not currently recyclable in usual household waste. We recommend taking them to a dedicated medicine recycling collection point. In 2024 Allevia is working together with Superdrug’s first medicine packet recycling programme so that you can recycle your blisters in stores.
Manufacturing
At Allevia, we want to play our part in the global movement to create a healthier planet. Our manufacturing sites in Sanofi Consumer Healthcare implement daily actions who drove concrete results already :
Climate Action
In all our Sanofi manufacturing sites, we are taking action to decarbonize our operations through energy efficiency programs, sourcing renewable electricity and switching from fossil fuels to biomass, biogas, heat pumps etc. By 2025, we aim to have achieved a 70% reduction in CO2e emission across Scopes 1 and 2, vs our 2019 baseline and as of 2022, we have achieved a 41% reduction. Our Allevia Compiegne site already sources 100% of its electricity from renewable sources.
Reduce waste and increase circularity
In all our manufacturing sites, we are working to reduce waste and increase circularity. By 2025 we aim to achieve zero waste to landfill and have a material recovery rate of 90%. Today, 7/13 sites already achieved zero waste to landfill including our Allevia Compeigne site.
Protect natural ecosystems
In all our manufacturing sites, we are aiming at preserving our planet's natural resources: As of 2022, all sites have engaged specific programs targeting pharmaceutical residues in the water stream . And we are aiming at reduce our water withdrawals by 20% by 2030 vs 2019. All manufacturing sites located in sensitive natural areas will also developed Biodiversity management plans by 2030.
Our commitment to sustainability doesn't stop at Allevia. It's a family affair.
Take a peek behind the scenes and see how our parent company, Sanofi, is shaping a brighter, healthier future for communities and our planet. Dive deeper into our exciting journey on our corporate site. But this is just the beginning...
- Simpson K, Jarvis B. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs. 2000 Feb;59(2):301-21. DOI: 10.2165/00003495-200059020-00020.
MAT-XU-2400995 (V1.0) March 2024